Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06520, United States.
DNA Repair (Amst). 2012 Apr 1;11(4):381-90. doi: 10.1016/j.dnarep.2012.01.004. Epub 2012 Feb 15.
Approximately 30% of human tumors sequenced to date harbor mutations in the POLB gene that are not present in matched normal tissue. Many mutations give rise to enzymes that contain non-synonymous single amino acid substitutions, several of which have been found to have aberrant activity or fidelity and transform cells when expressed. The DNA Polymerase β (Pol β) variant Asp160Asn (D160N) was first identified in a gastric tumor. Expression of D160N in cells induces cellular transformation as measured by hyperproliferation, focus formation, anchorage-independent growth and invasion. Here, we show that D160N is an active mutator polymerase that induces complex mutations. Our data support the interpretation that complex mutagenesis is the underlying mechanism of the observed cellular phenotypes, all of which are linked to tumorigenesis or tumor progression.
迄今为止,约有 30%的测序人类肿瘤存在 POLB 基因突变,而这些突变在匹配的正常组织中并不存在。许多突变产生的酶含有非同义的单个氨基酸取代,其中一些已被发现具有异常的活性或保真度,并在表达时转化细胞。DNA 聚合酶 β (Pol β) 变体 Asp160Asn (D160N) 最初是在胃肿瘤中发现的。细胞中 D160N 的表达如通过过度增殖、焦点形成、非锚定依赖性生长和侵袭来测量的那样诱导细胞转化。在这里,我们表明 D160N 是一种具有活性的诱变聚合酶,可诱导复杂突变。我们的数据支持这样的解释,即复杂的诱变是观察到的细胞表型的潜在机制,所有这些表型都与肿瘤发生或肿瘤进展有关。